Filing Details
- Accession Number:
- 0000899243-20-035406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 21:40:04
- Reporting Period:
- 2020-12-23
- Accepted Time:
- 2020-12-28 21:40:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815185 | W. Jason Myers | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-23 | 66,421 | $51.54 | 518,328 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-23 | 53,653 | $52.62 | 464,675 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-23 | 5,007 | $53.38 | 459,668 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-23 | 100 | $54.04 | 459,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-24 | 24,161 | $47.03 | 435,407 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-24 | 5,858 | $47.85 | 429,549 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-24 | 14,800 | $49.04 | 414,749 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-24 | 3,752 | $49.77 | 410,997 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-24 | 400 | $50.58 | 410,597 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on October 1, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $51.03 to $52.02 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $52.03 to $53.02 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $53.03 to $53.93 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $46.48 to $47.47 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $47.48 to $48.45 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $48.50 to $49.49 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $49.53 to $50.15 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $50.55 to $50.65 per share.
Billionaire Hedge Funds
